Top

European Journal of Nutrition

Published in:

01-12-2015 | Original Contribution

Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition

Authors: Yvonne Hagenlocher, Kristina Kießling, Michael Schäffer, Stephan C. Bischoff, Axel Lorentz

Published in: European Journal of Nutrition | Issue 8/2015

Abstract

Purpose

In terms of their involvement in allergic and inflammatory conditions, mast cells (MC) can be promising targets for medical agents in therapy. Because of their good compliance and effectiveness, phytochemicals are of great interest as new therapeutic tools in form of nutraceuticals. We found recently that cinnamon extract (CE) inhibits mast cell activation. Here, we analysed the effects of a major compound of CE, cinnamaldehyde (CA), on mast cell activation.

Methods

Release of prestored and de novo synthesised mediators as well as expression of pro-inflammatory cytokines and mast cell-specific proteases were analysed in RBL-2H3 cells or in human mast cells isolated from intestinal tissue (hiMC) treated with CA prior to stimulation by FcεRI crosslinking or IONO/PMA. The results were compared with the corresponding effects of CE.

Results

Following treatment with CA, release of β-hexosaminidase in IgE-dependent or IgE-independent activated RBL-2H3 cells was down-regulated in a dose-dependent manner to about 10 %. In hiMC, release of β-hexosaminidase was also significantly reduced, and release of LTC₄ and CXCL8 was almost completely inhibited by CA. Moreover, IgE-mediated expression of CXCL8, CCL2, CCL3 and CCL4 in hiMC was significantly down-regulated by CA. With the exception of the expression of the mast cell proteases tryptase and chymase, the inhibitory effects of CA were very similar to the effects shown for CE treatment. The reducing effect of CA on mast cell mediators—seen for long- and for short-term incubations—could be related to particular signalling pathways as CA caused a down-regulation in ERK as well as PLCγ1 phosphorylation.

Conclusions

CA decreases release and expression of pro-inflammatory mast cell mediators. This inhibitory action is similar to the effects observed for CE indicating CA as the main active compound in CE leading to its anti-allergic properties.

Kiyohara C, Tanaka K (2008) Genetic susceptibility to atopic dermatitis. Allergol Int 57:39–56CrossRef

Gupta R, Sheikh A, Strachan DP, Anderson HR (2007) Time trends in allergic disorders in the UK. Thorax 62:91–96CrossRef

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54 e42CrossRef

Chai OH, Han E-H, Lee H-K, Song CH (2011) Mast cells play a key role in Th2 cytokine dependent asthma model through production of adhesion molecules by liberation of TNF-α. Exp Mol Med 43:35–43CrossRef

Jacob C, Yang P-C, Darmoul D, Amadesi S, Saito T, Cottrell GS, Coelho A-M, Singh P, Grady EF, Perdue M, Bunnett NW (2005) Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and β-arrestins. J Biol Chem 280:31936–31948CrossRef

Hamilton MJ, Sinnamon MJ, Lyng GD, Glickman JN, Wang X, Xing W, Krilis SA, Blumberg RS, Adachi R, Lee DM, Stevens RL (2011) Essential role for mast cell tryptase in acute experimental colitis. PNAS 108:290–295CrossRef

Larmonier CB, Midura-Kiela MT, Ramalingam R, Laubitz D, Janikashvili N, Larmonier N, Ghishan FK, Kiela PR (2011) Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis 17:503–515CrossRef

Sergent T, Piront N, Meurice J, Toussaint O, Schneider Y-J (2010) Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem Biol Interact 188:659–667CrossRef

Hagenlocher Y, Lorentz A (2015) Immunomodulation of mast cells by nutrients. Mol Immunol 63:25–31

10.

Itoh T, Hori Y, Atsumi T, Toriizuka K, Nakamura M, Maeyama T, Ando M, Tsukamasa Y, Ida Y, Furuichi Y (2012) Hot water extract of adzuki (Vigna angularis) suppresses antigen-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice. Phytother Res 26:1003–1011CrossRef

11.

Lee JH, Kim JW, Ko NY, Mun SH, Her E, Kim BK, Han JW, Lee HY, Beaven MA, Kim YM, Choi WS (2008) Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol 121:1225–1231CrossRef

12.

Li GZ, Chai OH, Song CH (2005) Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis. Exp Mol Med 37:290–296CrossRef

13.

Bischoff SC (2007) Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 7:93–104CrossRef

14.

Bischoff SC (2009) Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 31:185–205CrossRef

15.

Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9(11):1215–1223CrossRef

16.

Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of innate and acquired immunity. Nat Rev Immunol 8(6):478–486CrossRef

17.

Kopeć A, Panaszek B, Fal AM (2006) Intracellular signaling pathways in IgE-dependent mast cell activation. Arch Immunol Ther Exp 54:393–401CrossRef

18.

Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA (2009) Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. JACN 28(1):16–21CrossRef

19.

Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV (2006) Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singap Med J 47(10):858–863

20.

Nahas R, Moher M (2009) Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 55:591–596

21.

Kwon HK, Hwang JS, So JS et al (2010) Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 10:392–401CrossRef

22.

Bai SK, Lee SJ, Na HJ et al (2005) Beta-carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med 37(4):323–334CrossRef

23.

Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, Kaul-Ghanekar R (2010) Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 10:210–221CrossRef

24.

Hagenlocher Y, Bergheim I, Zacheja S, Schäffer M, Bischoff SC, Lorentz A (2013) Cinnamon extract inhibits degranulation and de novo synthesis of inflammatory mediators in mast cells. Allergy 68(4):490–497CrossRef

25.

Corren J, Lemay M, Lin YRL, Randolph RK (2008) Clinical and biochemical effects of a combination botanical product (ClearGuard™) for allergy: a pilot randomized double-blind placebo-controlled trial. J Nutr 7:20–28CrossRef

26.

Gruenwald J, Freder J, Armbruester N (2010) Cinnamon and health. Crit Rev Food Sci Nutr 50(9):822–834CrossRef

27.

Chericoni S, Prieto JM, Iacopini P, Cioni P, Morelli I (2005) In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite-induced oxidative processes. J Agric Food Chem 53(12):4762–4765CrossRef

28.

Zhang J-H, Liu L-Q, He Y-L, Kong W-J, Huang S-A (2010) Cytotoxic effect of transcinnamaldehyde on human leukemia K562 cells. Acta Pharmacol Sin 31:861–866CrossRef

29.

Cabello CM, Bair WB III, Lamore SD, Ley S, Bause AS, Azimian S, Wondrak GT (2009) The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med 46:220–231CrossRef

30.

Hayashi K, Imanishi N, Kashiwayama Y, Kawano A, Terasawa K, Shimada Y, Ochiai H (2007) Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res 74:1–8CrossRef

31.

Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K (2013) Antibiofilm effect of plant derived antimicrobials on Listeria monocytogenes. Food Microbiol 36:79–89CrossRef

32.

Kollanoor-Johny A, Mattson T, Baskaran SA, Amalaradjou MA, Babapoor S, March B, Valipe S, Darre M, Hoagland T, Schreiber D et al (2012) Reduction of Salmonella enterica serovar enteritidis colonization in 20-day-old broiler chickens by the plant-derived compounds trans-cinnamaldehyde and eugenol. Appl Environ Microbiol 78:2981–2987CrossRef

33.

Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, Rao LV, Habibullah CM, Sechi LA, Ahmed N (2005) Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob 4:1–7CrossRef

34.

Alpizar YA, Gees M, Sanchez A, Apetrei A, Voets T, Nilius B, Talavera K (2013) Bimodal effects of cinnamaldehyde and camphor on mouse TRPA1. Pflugers Arch-Eur J Physiol 465:853–864CrossRef

35.

Huang B, Yuan HD, Kim DY, Quan HY, Chung SH (2011) Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-γ (PPARγ) and AMP-activated protein kinase (AMPK) pathways. J Agric Food Chem 59:3666–3673CrossRef

36.

Anand P, Murali KY, Tandon V, Murthy PS, Chandra R (2010) Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem Biol Interact 186:72–81CrossRef

37.

Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, Chen ST, Chang ST (2008) Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol 46:220–231CrossRef

38.

Lorentz A, Sellge G, Bischoff SC (2015) Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 1220:163–177CrossRef

39.

Feuser K, Feilhauer K, Staib L, Bischoff SC, Lorentz A (2011) Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Mol Immunol 48:546–552CrossRef

40.

Schwartz LB, Austen KF, Wasserman SI (1979) Immunological release of betahexosaminidase and beta-glucoronidase from purified rat serosal mast cells. J Immunol 123:1445–1450

41.

Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP et al (2005) IL-4 induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-FOS. J Immunol 174:6751–6756CrossRef

42.

Ehlers D, Hilmer S, Bartholomae S (1995) HPLC analysis of supercritical CO₂ cinnamon and cassia extracts in comparison with cinnamon and cassia oils. Z Lebensm Unters Forsch 200:282–288CrossRef

43.

Kageyama-Yahara N, Wang X, Katagiri T, Wang P, Yamamoto T, Tominaga M, Kadowaki M (2011) Suppression of phospholipase Cγ1 phosphorylation by cinnamaldehyde inhibits antigen-induced extracellular calcium influx and degranulation in mucosal mast cells. Biochem Biophys Res Commun 416:283–288CrossRef

44.

Lorentz A, Klopp I, Gebhardt T, Manns MP, Bischoff SC (2003) Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptormediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 111:1062–1068CrossRef

45.

Kimata M, Inagaki N, Kato T, Miura T, Serizawa I, Nagai H (2000) Roles of mitogenactivated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol 60:589–594CrossRef

46.

Kuehn HS, Swindle EJ, Kim M-S, Beaven MA, Metcalfe DD, Gilfillan AM (2008) The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigenstimulated mast cells. J Immunol 181:7706–7712CrossRef

47.

Lee Y-N, Tuckerman J, Nechushtan H, Schutz G, Razin E, Angel P (2004) c-Fos as a regulator of degranulation and cytokine production in FcεRI-activated mast cells. J Immunol 173:2571–2577CrossRef

48.

Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:1263–1293CrossRef

49.

Banks C, Bateman A, Payne R, Johnson P, Sheron N (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J Pathol 199:28–35CrossRef

50.

Matsuda R, Koide T, Tokoro C, Yamamoto T, Godai T, Morohashi T, Fujita Y, Takahashi D, Kawana I, Suzuki S, Umemura S (2009) Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease. Inflamm Bowel Dis 15:328–334CrossRef

51.

Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M (1999) Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 155:331–336CrossRef

52.

Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509–1515CrossRef

53.

Wastling JM, Scudamore CL, Thornton EM, Newlands GFJ, Miller HRP (1997) Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its upregulation during intestinal nematode infection. Immunology 90:308–313CrossRef

54.

Kim HM, Lee EH, Kim CY, Chung JG, Kim SH, Lim JP, Shin TY (1997) Antianaphylactic properties of eugenol. Pharmacol Res 36(6):475–480CrossRef

55.

Lee JH, Kim JW, Ko NY, Mun SH, Kim DK, Kim JD, Kim HS, Lee KR, Kim YK, Radinger M, Her E, Choi WS (2008) Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells. Clin Exp Allergy 38:794–804CrossRef

Title: Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition
Authors: Yvonne Hagenlocher
Kristina Kießling
Michael Schäffer
Stephan C. Bischoff
Axel Lorentz
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nutrition / Issue 8/2015
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-014-0810-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2015

Prospective relevance of fruit and vegetable consumption and salt intake during adolescence for blood pressure in young adulthood

Mediterranean diet and cognitive decline over time in an elderly Mediterranean population

Angiotensin-converting enzyme gene insertion/deletion polymorphism in nutritional disorders in children

Inhibitory and synergistic effects of natural olive phenols on human platelet aggregation and lipid peroxidation of microsomes from vitamin E-deficient rats

A novel Mediterranean diet index from Lebanon: comparison with Europe

Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page